GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Instem PLC (LSE:INS) » Definitions » Price-to-Owner-Earnings

Instem (LSE:INS) Price-to-Owner-Earnings : 30.74 (As of May. 20, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Instem Price-to-Owner-Earnings?

As of today (2024-05-20), Instem's share price is £8.30. Instem's Owner Earnings per Share (TTM) ended in Dec. 2022 was £0.27. It's Price-to-Owner-Earnings for today is 30.74.


The historical rank and industry rank for Instem's Price-to-Owner-Earnings or its related term are showing as below:

LSE:INS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.92   Med: 28.02   Max: 119.81
Current: 30.74

During the past 13 years, the highest Price-to-Owner-Earnings of Instem was 119.81. The lowest was 9.92. And the median was 28.02.


LSE:INS's Price-to-Owner-Earnings is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 20.705 vs LSE:INS: 30.74

As of today (2024-05-20), Instem's share price is £8.30. Instem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £0.14. Therefore, Instem's PE Ratio for today is 58.45.

As of today (2024-05-20), Instem's share price is £8.30. Instem's EPS without NRI for the trailing twelve months (TTM) ended in was £0.33. Therefore, Instem's PE Ratio without NRI for today is 25.46.

During the past 13 years, Instem's highest PE Ratio without NRI was 47.38. The lowest was 12.68. And the median was 22.85.


Instem Price-to-Owner-Earnings Historical Data

The historical data trend for Instem's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instem Price-to-Owner-Earnings Chart

Instem Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.62 47.07 18.49 29.60 26.30

Instem Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 29.60 - 26.30 -

Competitive Comparison of Instem's Price-to-Owner-Earnings

For the Health Information Services subindustry, Instem's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instem's Price-to-Owner-Earnings Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Instem's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Instem's Price-to-Owner-Earnings falls into.



Instem Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Instem's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=8.30/0.27
=30.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instem  (LSE:INS) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Instem Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Instem's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Instem (LSE:INS) Business Description

Traded in Other Exchanges
N/A
Address
Diamond Way, Stone Business Park, Stone, Staffordshire, GBR, ST15 0SD
Instem PLC acts as a supplier of IT applications and technology-enabled outsourced services to the global health and life sciences community. Its segments include Study Management, Regulatory Solutions, and In Silico Solutions, Clinical Trial Acceleration. The company generates maximum revenue from Study Management. Geographically, it derives a majority of its revenue from the United States and also has a presence in the Europe and Rest of the World. Its portfolio of software solutions includes Instem Cloud, SEND Data Conversion, KnowledgeScan, SENDReady Consulting, Solution Deployment, Validation, Data Management, and Regulatory Information Management.

Instem (LSE:INS) Headlines

No Headlines